$FDS

Goldman Sachs Adjusts PT on FactSet Research Systems to $237 From $236, Keeps Sell Rating

Goldman Sachs raised its price target on FactSet Research Systems from $236 to $237, maintaining a 'Sell' rating. The stock closed at $269.95 on 2026-09-30, with a 5-day change of +3.84% and a 1st Jan change of -3.39%. The rating is based on valuation, EPS revisions, and visibility metrics.

Original reporting
Published Oct 1, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 11:16 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$FDS
Bearish
medium confidence
Mentioned
$FDS
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$FDSBearishMed
01

Why it matters

The minimal target raise is unlikely to shift market sentiment, and the sell rating may keep the stock under pressure.

02

Market read

A modest analyst price target adjustment with a sell rating offers limited trading impetus; traders may monitor for larger catalyst.

03

What to watch

Potential upcoming earnings or product announcements could change the outlook.

Relevance 5/10Novelty 5/10Timing: pre‑market

Background

Goldman Sachs issued a new research note adjusting FactSet's price target by $1 while keeping its sell recommendation.

Company-level read

Ticker impact

$FDSBearishMedium confidence
Context

Goldman Sachs raised FactSet's price target to $237 from $236 while maintaining a sell rating.

Expected impact

likely modest pressure as the sell rating outweighs the small target raise

Evidence & confidence

The PT bump is only $1 and the sell stance signals continued downside risk, so traders may see little upside.

Market effects

Minor impact on the data‑analytics sector; analysts may reassess peers.

Limited to US equity markets where FactSet trades.

Low; the change affects only a single mid‑cap stock.

Counterpoint

Some traders may view the slight PT increase as a buying opportunity despite the sell rating.

Key entities

  • Goldman Sachs

    Investment bank providing the price target and rating.

  • FactSet Research Systems Inc.

    Provider of financial data and analytics platforms.

Related articles

$FDSHigh

FactSet (FDS) Stock Trades Up, Here Is Why

FactSet (FDS) shares rose 4.8% after announcing an expanded partnership with Scotiabank's Scotia Wealth Management. The deal integrates FactSet's research and intelligence platform into Scotia's advisor and investment operations. FactSet reported Q3 2026 revenue of $634.7M, with organic growth of 7.1%, and forecasted fiscal 2027 revenue between $2.6B and $2.625B. The stock is near its 52-week high of $313.55.

$FDSHighAI 8/10

What Is Wall Street Really Pricing Into FactSet (FDS)?

FactSet Research Systems (FDS) reported strong fiscal 2026 results, with 7% organic growth in annual subscription value and AI-related products contributing significantly. Despite this, its stock trades at a forward P/E of 13.95, reflecting market skepticism about AI disruption. Management expects slower growth in 2027 and margins to recover modestly. Short interest is high, and the next Investor Day will be crucial.

$FDSHighAI 8/10

FactSet (FDS) Q4 2026 Earnings Call Transcript

FactSet (FDS) reported Q4 2026 organic ASV growth of 7.0% YoY, reaching $2.568B, and Q4 revenue of $634.7M, up 6.3%. Adjusted EPS grew 11.6% YoY to $4.52. Full-year adjusted operating margin declined 1.8% to 34.5%. AI-related ASV accounted for at least 10% of new ASV. Guidance for 2027 includes 5-6.5% organic ASV growth and 5-6% revenue growth. Share repurchases totaled $644M, reducing shares outstanding by 7%.